Anti-miR-712 effectively suppresses d-flow-induced miR-712 expression and increases TIMP3 expression.[175] Anti-miR-712 also inhibits vascular hyperpermeability, thereby significantly reducing atherosclerosis lesion development and immune cell infiltration.[175]